Filing Details
- Accession Number:
- 0001179110-17-004273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-08 18:11:27
- Reporting Period:
- 2017-03-06
- Filing Date:
- 2017-03-08
- Accepted Time:
- 2017-03-08 18:11:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1607733 | K Brett Haumann | C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080 | Svp Clin Dev & Chief Med Ofc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2017-03-06 | 13,576 | $31.52 | 163,895 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-03-07 | 424 | $30.80 | 163,471 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices from $31.18 to $32.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
